Effects of scopolamine and ketamine on reconsolidation of morphine conditioned place preference in rats

Behavioural Pharmacology

Volumn 19, Issue 3, 2008, Pages 211-216

  Zhai, Haifeng ^a   Wu, Ping ^a   Chen, Suqing ^a   Li, Fangqiong ^a   Liu, Yu ^a   Lu, Lin ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Cholinergic transmission; Conditioned place preference; Memory reconsolidation; N methyl D aspartate receptor; Rat; Relapse

Indexed keywords

KETAMINE; MORPHINE; SCOPOLAMINE BROMIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG REEXPOSURE; MALE; NONHUMAN; PLACE PREFERENCE; RAT;

ANALGESICS; ANIMALS; CONDITIONING (PSYCHOLOGY); INJECTIONS, INTRAPERITONEAL; KETAMINE; MALE; MEMORY; MORPHINE; MUSCARINIC ANTAGONISTS; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SCOPOLAMINE; TIME FACTORS;

EID: 43449092204     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282fe88a0     Document Type: Article

References (39)

1. Bespalov A, Dumpis M, Piotrovsky L, Zvartau E (1994). Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur J Pharmacol 264:233-239.
2. Del Pozo E, Barrios M, Baeyens JM (1996). The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice. Psychopharmacology (Berl) 125:209-213.
3. Dong Z, Han H, Wang M, Xu L, Hao W, Cao J (2006). Morphine conditioned place preference depends on glucocorticoid receptors in both hippocampus and nucleus accumbens. Hippocampus 16:809-813.
4. Harris GC, Hummel M, Wimmer M, Mague SD, Aston-Jones G (2007). Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function. Neuroscience 147:583-591.
5. Kim HS, Jang CG, Park WK (1996). Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol Biochem Behav 55:11-17.
6. Lu L, Xu NJ, Ge X, Yue W, Su WJ, Pei G, Ma L (2002). Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization. Psychopharmacology (Berl) 159:125-132.
7. Lu L, Chen H, Su W, Ge X, Yue W, Su F, Ma L (2005). Role of withdrawal in reinstatement of morphine-conditioned place preference. Psychopharmacology (Berl) 181:90-100.
8. Lu L, Koya E, Zhai H, Hope BT, Shaham Y (2006). Role of ERK in cocaine addiction. Trends Neurosci 29:695-703.
9. McIntyre CK, Ragozzino ME, Gold PE (1998). Intra-amygdala infusions of scopolamine impair performance on a conditioned place preference task but not a spatial radial maze task. Behav Brain Res 95:219-226.
10. Milekic MH, Brown SD, Castellini C, Alberini CM (2006). Persistent disruption of an established morphine conditioned place preference. J Neurosci 26:3010-3020.
11. Miller CA, Marshall JF (2005). Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 47:873-884.
12. Miller CA, Sweatt JD (2006). Amnesia or retrieval deficit? Implications of a molecular approach to the question of reconsolidation. Learn Mem 13:498-505.
13. Misanin JR, Miller RR, Lewis DJ (1968). Retrograde amnesia produced by electroconvulsive shock after reactivation of a consolidated memory trace. Science 160:554-555.
14. Mueller D, Perdikaris D, Stewart J (2002). Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res 136:389-397.
15. Nader K (2003). Memory traces unbound. Trends Neurosci 26:65-72.
16. Nader K, Schafe GE, Le Doux JE (2000a). Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406:722-726.
17. Nader K, Schafe GE, LeDoux JE (2000b). The labile nature of consolidation theory. Nat Rev Neurosci 1:216-219.
18. Popik P, Danysz W (1997). Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. J Pharmacol Exp Ther 280:854-865.
19. Popik P, Kolasiewicz W (1999). Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn Schmiedebergs Arch Pharmacol 359:288-294.
20. Power AE, Vazdarjanova A, McGaugh JL (2003). Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem 80:178-193.
21. Ribeiro Do Couto B, Aguilar MA, Rodriguez-Arias M, Minarro J (2005). Long-lasting rewarding effects of morphine induced by drug primings. Brain Res 1050:53-63.
22. Riedel G, Platt B, Micheau J (2003). Glutamate receptor function in learning and memory. Behav Brain Res 140:1-47.
23. Robinson MJ, Franklin KB (2007a). Central but not peripheral beta-adrenergic antagonism blocks reconsolidation for a morphine place preference. Behav Brain Res 182:129-134.
24. Robinson MJ, Franklin KB (2007b). Effects of anisomycin on consolidation and reconsolidation of a morphine-conditioned place preference. Behav Brain Res 178:146-153.
25. Sakoori K, Murphy NP (2005). Maintenance of conditioned place preferences and aversion in C57BL6 mice: effects of repeated and drug state testing. Behav Brain Res 160:34-43.
26. Sharifzadeh M, Haghighat A, Tahsili-Fahadan P, Khalaj S, Zarrindast MR, Zamanian AR (2006). Intra-hippocampal inhibition of protein kinase aII attenuates morphine-induced conditioned place preference. Pharmacol Biochem Behav 85:705-712.
27. Suzuki T, Kato H, Tsuda M, Suzuki H, Misawa M (1999). Effects of the noncompetitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice. Life Sci 64:PL151-PL156.
28. Suzuki T, Kato H, Aoki T, Tsuda M, Narita M, Misawa M (2000). Effects of the noncompetitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. Life Sci 67:383-389.
29. Tzschentke TM (1998). Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672.
30. Tzschentke TM (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227-462.
31. Tzschentke TM, Schmidt WJ (1995). N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193:37-40.
32. Valjent E, Corbille AG, Bertran-Gonzalez J, Herve D, Girault JA (2006). Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci U S A 103:2932-2937.
33. Wang J, Fang Q, Liu Z, Lu L (2006). Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress-or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) 185:19-28.
34. Wang X, Cen X, Lu L (2001). Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol 432:153-161.
35. Yim AJ, Moraes CR, Ferreira TL, Oliveira MG (2006). Protein synthesis inhibition in the basolateral amygdala following retrieval does not impair expression of morphine-associated conditioned place preference. Behav Brain Res 171:162-169.
36. Zarrindast MR, Fattahi Z, Rostami P, Rezayof A (2005). Role of the cholinergic system in the rat basolateral amygdala on morphine-induced conditioned place preference. Pharmacol Biochem Behav 82:1-10.
37. Zhai HF, Zhang ZY, Zhao M, Qiu Y, Ghitza UE, Lu L (2007). Conditioned drug reward enhances subsequent spatial learning and memory in rats. Psychopharmacology 195:193-201.
38. Zhao M, Zhang ZY, Zhai HF, Qiu Y, Lu L (2007). Effects of stress during reactivation on rewarding memory. Neuroreport 18:1153-1156.
39. Zhou H, Ge X, Wang LZ, Ma L, Pei G (1999). Attenuation of morphine tolerance and dependence in scopolamine-treated rats. Neuroreport 10:2007-2010.